ArticleScientific reports2025
Size reduction of selenium nanoparticles synthesized from yeast beta glucan using cold atmospheric plasma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Biogenic synthesis and characterization of selenium nanoparticles by halotolerant Bacillus sonorensis 2MNHR.Applied microbiology and biotechnology · 2026Article
- Anti-Aging Potential of Biogenic Selenium Nanoparticles and Selenium/Polysaccharides Nanoconjugate Biosynthesized byAntioxidants (Basel, Switzerland) · 2026Article
- Gender-specific and dose-dependent responses to L-se-methylselenocysteine are mediated by the gut microbiota-metabolite axis: implications for intestinal homeostasis and safe clinical application.Frontiers in nutrition · 2026Article
- Biogenic Selenium Nanoparticles fromPharmaceutics · 2025Article
- Selenium Nanoparticles as Versatile Delivery Tools.Pharmaceutics · 2025Review
- Green synthesis of silver iodide nanoparticles from Kluyveromyces marxianus M59 beta-glucan: characterization and anticancer activity.BMC biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The limitations of both inorganic and organic selenium sources, such as low bioavailability and potential toxicity, have driven research towards selenium nanoparticles (SeNPs). In this study, β-glucan was extracted from the cell wall of Kluyveromyces marxianus M59 and subsequently carboxymethylated to enhance its water solubility. Carboxymethylated β-glucan was then utilized for the synthesis of selenium nanoparticles (SeNPs), and their sizes were determined using Scanning Electron Microscopy (SEM) analysis. To reduce the size of larger nanoparticles, Cold Atmospheric Plasma (CAP) treatment was applied, resulting in an approximately 82.4% decrease in particle size. The SeNPs obtained ranged in size from 180 to 83 nm. The synthesized SeNPs were characterized using UV-Vis Spectrophotometry, Fourier-Transform Infrared Spectroscopy (FTIR), and X-ray Diffraction (XRD) analysis. The absorption peak of SeNPs was detected at 330 nm, further confirming their amorphous nature. Additionally, the biological activities of SeNPs, including their antimicrobial, antibiofilm, and antioxidant properties, were investigated. When the antibiofilm activity of SeNPs was evaluated, the highest inhibition rate (43.6 ± 0.1%) was observed at a concentration of 5 mg/mL. In contrast, regarding antimicrobial activity, SeNPs exhibited limited inhibition zones at low concentrations, with a maximum inhibition diameter of 1.20 mm recorded. Antioxidant activity was evaluated through 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, superoxide anion scavenging, and hydroxyl radical scavenging assays. The highest antioxidant activity was determined at 5 mg/mL SeNP concentration (47.7%) at DPPH method. The cytotoxic effects of SeNPs were evaluated on both healthy (L929) and lung cancer (A549) cell lines. The IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.